IN the summer of 2019, a mother in Nashville, Tennessee in the United States, with a seemingly incurable genetic disorder finally found an end to her suffering by editing her genome.
Victoria Grays recovery from sickle cell disease, which had caused her painful seizures, came in a year of breakthroughs in one of the hottest areas of medical research gene therapy.
I have hoped for a cure since I was about 11, the 34-year-old said.
Since I received the new cells, I have been able to enjoy more time with my family without worrying about pain or an out-of-the-blue emergency.
Over several weeks, Grays blood was drawn so that doctors could get to the cause of her illness stem cells from her bone marrow that were making deformed red blood cells.
The stem cells were sent to a Scottish laboratory, where their DNA was modified using Crispr/Cas9 pronounced Crisper a new tool informally known as a molecular scissors.
The genetically-edited cells were transfused back into Grays veins and bone marrow. A month later, she was producing normal blood cells.
Medics warn that caution is necessary, but theoretically, she has been cured.
This is one patient. This is early results. We need to see how it works out in other patients, said her doctor, Haydar Frangoul, at the Sarah Cannon Research Institute in Nashville.
But these results are really exciting.
In Germany, a 19-year-old woman was treated with a similar method for a different blood disease beta thalassemia.
She had previously needed 16 blood transfusions per year. Nine months later, she is completely free of that burden.
For decades, the DNA of living organisms such as corn and salmon has been modified. But Crispr, invented in 2012, made gene editing more widely accessible.
It is much simpler than preceding technology, cheaper and easy to use in small labs.
The technique has given new impetus to the perennial debate over the wisdom of humanity manipulating life itself.
Its all developing very quickly, said French geneticist Emmanuelle Charpentier, one of Crisprs inventors and the co-founder of Crispr Therapeutics, the biotech company conducting the clinical trials involving Gray and the German patient.
Crispr was the latest breakthrough in a year of great strides in gene therapy, a medical adventure that started three decades ago, when the first TV telethons were raising money for children with muscular dystrophy.
Scientists practising the technique insert a normal gene into cells containing a defective gene.
It does the work the original could not, such as making normal red blood cells in Grays case or making tumour-killing super white blood cells for a cancer patient.
Crispr goes even further: instead of adding a gene, the tool edits the genome itself.
After decades of research and clinical trials on a genetic fix to genetic disorders, 2019 saw a historic milestone: approval to bring to market the first gene therapies for a neuromuscular disease in the US and a blood disease in the European Union.
They join several other gene therapies bringing the total to eight approved in recent years to treat certain cancers and an inherited blindness.
Serge Braun, the scientific director of the French Muscular Dystrophy Association, sees 2019 as a turning point that will lead to a medical revolution.
Twenty-five, 30 years, thats the time it had to take, he said. It took a generation for gene therapy to become a reality. Now, its only going to go faster.
Just outside Washington, at the US National Institutes of Health (NIH), researchers are also celebrating a breakthrough period.
We have hit an inflection point, said US NIHs associate director for science policy Carrie Wolinetz.
These therapies are exorbitantly expensive, however, costing up to US$2 million (RM8.18 million) meaning patients face grueling negotiations with their insurance companies.
They also involve a complex regimen of procedures that are only available in wealthy countries.
Gray spent months in hospital getting blood drawn, undergoing chemotherapy, having edited stem cells reintroduced via transfusion and fighting a general infection.
You cannot do this in a community hospital close to home, said her doctor.
However, the number of approved gene therapies will increase to about 40 by 2022, according to Massachusetts Institute of Technology (MIT) researchers.
They will mostly target cancers and diseases that affect muscles, the eyes and the nervous system.
In this Oct 10, 2018, photo, He speaks during an interview at his laboratory in Shenzhen, China. The scientist was recently sentenced to three years in prison for practicing medicine illegally and fined 3 million yuan (RM1.76 million). AP
Another problem with Crispr is that its relative simplicity has triggered the imaginations of rogue practitioners who dont necessarily share the medical ethics of Western medicine.
In 2018 in China, scientist He Jiankui triggered an international scandal and his excommunication from the scientific community when he used Crispr to create what he called the first gene-edited humans.
The biophysicist said he had altered the DNA (deoxyribonucleic acid) of human embryos that became twin girls Lulu and Nana.
His goal was to create a mutation that would prevent the girls from contracting HIV (human immunodeficiency virus), even though there was no specific reason to put them through the process.
That technology is not safe, said Kiran Musunuru, a genetics professor at the University of Pennsylvania, explaining that the Crispr scissors often cut next to the targeted gene, causing unexpected mutations.
Its very easy to do if you dont care about the consequences, he added.
Despite the ethical pitfalls, restraint seems mainly to have prevailed so far.
The community is keeping a close eye on Russia, where biologist Denis Rebrikov has said he wants to use Crispr to help deaf parents have children without the disability.
There is also the temptation to genetically edit entire animal species, e.g. malaria-causing mosquitoes in Burkina Faso or mice hosting ticks that carry Lyme disease in the US.
The researchers in charge of those projects are advancing carefully however, fully aware of the unpredictability of chain reactions on the ecosystem.
Charpentier doesnt believe in the more dystopian scenarios predicted for gene therapy, including American biohackers injecting themselves with Crispr technology bought online.
Not everyone is a biologist or scientist, she said.
And the possibility of military hijacking to create soldier-killing viruses or bacteria that would ravage enemies crops?
Charpentier thinks that technology generally tends to be used for the better.
Im a bacteriologist -- weve been talking about bioterrorism for years, she said. Nothing has ever happened. AFP Relaxnews
We're sorry, this article is unavailable at the moment. If you wish to read this article, kindly contact our Customer Service team at 1-300-88-7827. Thank you for your patience - we're bringing you a new and improved experience soon!
Article type: metered
User Type: anonymous web
Campaign ID: 7
Cxense type: free
User access status: 3
- Scientist Who Discovered BRCA1 Gene to Give Free Talk on Cancer And Genetics - Noozhawk - January 19th, 2020
- Genetic testing firm 23andMe is first to create a drug using its customers' DNA - The Times - January 19th, 2020
- Hackensack Meridian Health Center for Discovery and Innovation to Host Genomic Medicine Symposium - P&T Community - January 19th, 2020
- 11 Year-Old Bertrand Might Cant Cry Scientists Have Now Discovered Why - SciTechDaily - January 19th, 2020
- Transposons Identified as Likely Cause of Undiagnosed Diseases - The Scientist - January 19th, 2020
- Do genetic ancestry tests know if you're Palestinian? A cautionary tale of race and science - ABC News - January 19th, 2020
- Controlling Our Own Evolution: What is the Future of Gene-Editing? - The Globe Post - January 19th, 2020
- There is a new player in adult bone healing - Baylor College of Medicine News - January 19th, 2020
- Air Pollution, Evolution, and the Fate of Billions of Humans - The New York Times - January 19th, 2020
- A New York Times column on 'Jewish genius' draws criticism for linking to a debunked University of Utah study - Salt Lake Tribune - January 5th, 2020
- Ambroxol Reverses Bone Damage in Girl With GD Type 1, Case Study Shows - Gaucher Disease News - January 5th, 2020
- Digid8 and the Emergence of DNA Matchmaking - Study Breaks - January 5th, 2020
- Etched in DNA: Decoding the secrets of the past - Christian Science Monitor - January 5th, 2020
- The Face of Science - Clemson World magazine - January 5th, 2020
- Aborting Babies Because They're Gay: Coming Soon to China - Patheos - January 5th, 2020
- Mutants among us: "Natural short sleepers" reveal the genetics of sleep - Inverse - January 5th, 2020
- The End of Infertility Is in Sight - UCSF News Services - January 5th, 2020
- Who is a Jew? DNA home testing adds new wrinkle to age-old debate - The Jewish News of Northern California - December 1st, 2019
- Humans and autoimmune diseases continue to evolve together - Medical News Today - December 1st, 2019
- Mutations in emerging autism gene tied to distinct traits - Spectrum - December 1st, 2019
- Gail Fisher's 'Dog Tracks': Spoiling you dog with extra food could cut short its life - The Union Leader - December 1st, 2019
- In a Wisconsin village, the doctor makes house calls and sees the rarest diseases on Earth - USA TODAY - December 1st, 2019
- Alzheimer's and Autism: Researchers Pinpoint Genetic Mutations Overlapping in Both Diseases - Being Patient - December 1st, 2019
- How do consumer DNA tests from the US and China stack up? - Abacus - December 1st, 2019
- Is Nature vs. Nurture an Outdated Concept? - The National Interest Online - December 1st, 2019
- Collection of genetic data leads to privacy concerns - The New Economy - December 1st, 2019
- Is sexual orientation genetic? Yes and no, an extensive study finds - Haaretz - November 19th, 2019
- Sexual orientation cannot be changed at will, lawyers argue - The Straits Times - November 19th, 2019
- Adam and Eve Are Possible: A Second Bite at the Genetic Apple - Christianheadlines.com - November 19th, 2019
- InterVenn Biosciences Announces Positive Interim Clinical Trial Results and Appoints Biotech Veteran Klaus Lindpaintner, M.D. as Chief Scientific and... - November 19th, 2019
- How maternal Zika infection results in newborn microcephaly - Baylor College of Medicine News - November 19th, 2019
- Dicerna scores broad, 'rest of liver' deal with Novo Nordisk, bagging $225M in cash to hit some 30 targets with RNAi platform - Endpoints News - November 19th, 2019
- Sexual orientation cannot be wilfully changed, say lawyers fighting to repeal Section 377A - The Straits Times - November 19th, 2019
- The American Heart Association's Annual Conference Comes to Philly This Weekend - Philadelphia magazine - November 19th, 2019
- Clear link between genetics and depressive symptoms uncovered - The Age - November 19th, 2019
- At-Home DNA Tests Still Need the 'Human Touch,' Say Panelists at Genomics Roundtable Workshop - National Academies of Sciences, Engineering, and... - November 19th, 2019
- How in utero Zika virus infection can lead to microcephaly in newborns: Baylor research - Outbreak News Today - November 19th, 2019
- Taller People have Increased Risk of Irregular Heartbeat - News18 - November 19th, 2019
- In Down syndrome mouse model, scientists reverse intellectual deficits with drugs - University of California - November 19th, 2019
- Alector Reports Recent Business Highlights and Third Quarter 2019 Financial Results - GlobeNewswire - November 19th, 2019
- One of the World's Greatest Geneticists, He Gave Up British Citizenship for India - The Better India - November 19th, 2019
- Section 377A constitutional challenge: Expert evidence reveal sexual orientation cannot be changed at will, lawyers argue - The Online Citizen - November 19th, 2019
- Co-creator of CRISPR lectures about future applications of genome editing technology - Daily Bruin - November 19th, 2019
- Connecting gene mutations, rare genetic diseases - Baylor College of Medicine News - October 28th, 2019
- Utah researchers discover link between certain brain cells and anxiety, OCD - KSL.com - October 28th, 2019
- UH Receives $2M to Study Cancer Risks of Environmental Toxins - Big Island Now - October 28th, 2019
- Genetic testing could keep you healthy. But what about personal info? - Deseret News - October 28th, 2019
- Student group works to foster diversity in the sciences - UChicago News - October 28th, 2019
- Takeaways from ASHG 2019 in Houston: Users of Bionano's Saphyr System Presented Validation Results for FSHD, Repeat Expansion Disorders and Digital... - October 28th, 2019
- DNA research holds the keys to human history but it's being weaponized by politicians - Haaretz - October 28th, 2019
- Scientists have created the first-ever 18-carbon ring, a major feat of molecular architecture - Massive Science - October 28th, 2019
- Law, Privacy and Genome Human Rights Failure in Russia - Putin's Fascination with Hitler's Eugenics Project - Communal News - October 28th, 2019
- Neural activity plays an important role in longevity - CMU The Tartan Online - October 28th, 2019
- Book Summary: Genetics and the Aryan Debate by Shrikant Talageri- I - IndiaFacts - October 28th, 2019
- Cryptocurrency News: This Week on Bitfinex, Tether, Coinbase, & More - May 25th, 2019
- Ripple Price Forecast: XRP vs SWIFT, SEC Updates, and More - May 25th, 2019
- Cryptocurrency News: Bitcoin ETFs, Andreessen Horowitz, and Contradictions in Crypto - May 25th, 2019
- Cryptocurrency News: Looking Past the Bithumb Crypto Hack - May 25th, 2019
- Cryptocurrency News: XRP Validators, Malta, and Practical Tokens - May 25th, 2019
- Cryptocurrency News: Bitcoin ETF Rejection, AMD Microchip Sales, and Hedge Funds - May 25th, 2019
- Cryptocurrency News: What You Need to Know This Week - May 25th, 2019
- Bitcoin Rise: Is the Recent Bitcoin Price Surge a Sign of Things to Come or Another Misdirection? - May 25th, 2019
- Cryptocurrency News: Vitalik Buterin Doesn’t Care About Bitcoin ETFs - May 25th, 2019
- Cryptocurrency News: New Exchanges Could Boost Crypto Liquidity - May 25th, 2019
- Human genetics - Wikipedia - May 5th, 2019
- Human Genetics - medschool.ucla.edu - May 5th, 2019
- Department of Human Genetics | The University of Chicago - May 5th, 2019
- Human genetics | biology | Britannica.com - May 2nd, 2019
- What is Bitcoin Cash? - finance.yahoo.com - April 29th, 2019
- Bitcoin Soars As Ethereum, Ripple's XRP, Bitcoin Cash, And ... - April 29th, 2019
- Bitcoin Cash - finance.yahoo.com - April 29th, 2019
- What is Bitcoin Cash? - Coin Rivet - April 29th, 2019
- Bitcoin Cash - Wikipedia - April 29th, 2019
- Ripple Price Forecast: XRP vs SWIFT, SEC Updates, and More - April 21st, 2019
- Cryptocurrency News: Looking Past the Bithumb Crypto Hack - April 21st, 2019
- Cryptocurrency News: This Week on Bitfinex, Tether, Coinbase, & More - April 21st, 2019
- Cryptocurrency News: XRP Validators, Malta, and Practical Tokens - April 21st, 2019
- Cryptocurrency News: Bitcoin ETFs, Andreessen Horowitz, and Contradictions in Crypto - April 21st, 2019
- Cryptocurrency News: New Exchanges Could Boost Crypto Liquidity - April 21st, 2019
- Cryptocurrency News: Bitcoin ETF Rejection, AMD Microchip Sales, and Hedge Funds - April 21st, 2019